Intrinsiqs

Is Praxis Precision Medicines, Inc. overvalued?

Praxis Precision Medicines, Inc. (PRAX) — key valuation metrics and fundamentals.

No verdict
Price
$280.78
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$7.83B
Dividend yield
0.0%
Return on equity
-34.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PRAX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.